Independent replication of polymorphisms predicting toxicity in breast cancer patients randomized between dose-dense and docetaxel-containing adjuvant chemotherapy.
| Author | |
|---|---|
| Abstract | :
Although pharmacogenomics has evolved substantially, a predictive test for chemotherapy toxicity is still lacking. We compared the toxicity of adjuvant dose-dense doxorubicin-cyclophosphamide (ddAC) and docetaxel-doxorubicin-cyclophosphamide (TAC) in a randomized multicenter phase III trial and replicated previously reported associations between genotypes and toxicity. |
| Year of Publication | :
2017
|
| Journal | :
Oncotarget
|
| Volume | :
8
|
| Issue | :
69
|
| Number of Pages | :
113531-113542
|
| Date Published | :
2017
|
| DOI | :
10.18632/oncotarget.22697
|
| Short Title | :
Oncotarget
|
| Download citation |